3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Myelodysplastic Syndromes
17
Lymphoma, Non-Hodgkin
13
Multiple Myeloma
12
Hodgkin Disease
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Leukemia, Lymphocytic, Chronic, B-Cell
10
Myeloproliferative Disorders
9
Recurrence
7
Melanoma
7
Leukemia, Myelomonocytic, Chronic
7
Leukemia, Biphenotypic, Acute
7
Anemia, Refractory, with Excess of Blasts
7
Lymphoma
6
Leukemia
6
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Waldenstrom Macroglobulinemia
4
Neuroblastoma
4
Lymphoma, B-Cell, Marginal Zone
4
Leukemia, Myelomonocytic, Juvenile
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Burkitt Lymphoma
4
Uveal Melanoma
3
Stomach Neoplasms
3
Primary Myelofibrosis
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Interventions
fludarabine phosphate
1
fludarabine
1
Herpes Zoster Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chickenpox
×
fludarabine phosphate
×
90 days
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled